518 results on '"SCHERMULY, RALPH THEO"'
Search Results
2. Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia
3. The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension
4. HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape
5. Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?
6. Pneumococcal hydrogen peroxide regulates host cell kinase activity
7. Experimental Models
8. A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding
9. Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle
10. Surgical protocol for pulmonary artery banding in mice to generate a model of pressure-overload-induced right ventricular failure
11. Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome
12. A novel noninvasive method for estimating right ventricular systolic pressure in rodents with pulmonary artery banding
13. Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
14. Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study.
15. Osteopontin in Pulmonary Hypertension
16. Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
17. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction
18. Supplementary Materials and Methods from A Combination Hybrid-Based Vaccination/Adoptive Cellular Therapy to Prevent Tumor Growth by Involvement of T Cells
19. Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis
20. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice
21. Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension
22. Experimental Models
23. Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
24. Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talk
25. Evaluating Systolic and Diastolic Cardiac Function in Rodents Using Microscopic Computed Tomography
26. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension
27. Sox17 Deficiency Promotes Pulmonary Arterial Hypertension via HGF/c-Met Signaling
28. Circulating Microparticles Are Differentially Increased in Lowlanders and Highlanders with High Altitude Induced Pulmonary Hypertension during the Cold Season
29. Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: The role of phosphodiesterase 4
30. PDGF Receptor and its Antagonists: Role in Treatment of PAH
31. Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease
32. Comparative kinase activity profiling of pathogenic influenza A viruses reveals new anti- and pro-viral protein kinases
33. Rhodiola : an ordinary plant or a promising future therapy for pulmonary hypertension? a brief review
34. Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature
35. Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension
36. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
37. Corrigendum to “Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling” [International Journal of Cardiology 167 (2013) 2630–2637]
38. Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome
39. Animal models of pulmonary hypertension: role in translational research
40. Adenylate Kinase 4—A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways
41. Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model
42. Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension
43. Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
44. Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
45. Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice
46. IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension
47. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension
48. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice
49. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale
50. Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.